tiprankstipranks
Trending News
More News >
Vaccinex Inc (VCNX)
OTHER OTC:VCNX
US Market

Vaccinex (VCNX) Income Statement

Compare
308 Followers

Vaccinex Income Statement

Last quarter (Q4 2024), Vaccinex's total revenue was $213.00K, a decrease of -155.18% from the same quarter last year. In Q4, Vaccinex's net income was $-3.37M. See Vaccinex’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 601.00K$ 570.00K$ 100.00K$ 900.00K$ 50.00K
Gross Profit
$ 601.00K$ 570.00K$ 68.00K$ 731.00K$ 48.00K
Operating Expenses
$ 19.34M$ 23.45M$ 20.01M$ 23.22M$ 28.38M
Depreciation and Amortization
$ 94.00K$ 119.00K$ 207.00K$ 169.00K$ 307.00K
EBITDA
$ -18.54M$ -19.75M$ -19.61M$ -21.40M$ -28.05M
Operating Income
$ -18.73M$ -22.89M$ -19.91M$ -22.49M$ -28.33M
Other Income/Expenses
$ 101.00K$ 2.63M$ 91.00K$ 110.00K$ -520.00K
Pretax Income
$ -18.63M$ -20.25M$ -19.82M$ -22.38M$ -28.85M
Net Income
$ -18.63M$ -20.25M$ -19.72M$ -22.38M$ -28.85M
Per Share Metrics
Basic EPS
$ -8.88$ -43.68$ -97.59$ -163.80$ -322.50
Diluted EPS
$ -8.88$ -43.68$ -97.59$ -162.91$ -322.50
Weighted Average Shares Outstanding
2.10M 463.65K 202.08K 136.63K 89.46K
Weighted Average Shares Outstanding (Diluted)
2.10M 463.65K 202.08K 137.38K 89.46K
Currency in USD

Vaccinex Earnings and Revenue History